Related Experiment Video

Updated: May 1, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.3K

CRE26-062: Discordant Diagnostics: Heparin-Induced Thrombocytopenia With a Negative Serotonin Release Assay

Ronak S Patel1, Aditya Lakkamsani1, Samiuddin Syed1

  • 11Internal Medicine, Advocate Lutheran General Hospital, Park Ridge, IL.

Journal of the National Comprehensive Cancer Network : JNCCN
|April 29, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

174
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

7.1K

Related Experiment Videos

Last Updated: May 1, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.3K
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

174
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

7.1K

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K

Articles linked to this work by shared authors, journal, and citation graph.

Field-deployable supramolecular fluorescent sensing platform for selective dual-mode detection of thiamethoxam in complex environmental matrices.

Mikrochimica acta·2026

Postpartum Left Ventricular Dysfunction in Preeclampsia With Incidental Patent Ductus Arteriosus: A Multimodality Hemodynamic Assessment.

Cureus·2026

Case report of antepartum and postpartum spontaneous coronary artery dissection in a high-risk pregnancy.

European heart journal. Case reports·2026

Molecular recognition meets microcontroller: calixarene-based fluorescent sensors for selective detection of 2-nitrobenzaldehyde.

The Analyst·2026

Prone positioning in cone beam CT-guided robotic bronchoscopy case series: a strategy to minimize atelectasis and improve access to posteromedial lower lobe nodules.

Journal of thoracic disease·2025

Quinoline functionalized Tetramethoxyresorcin[4]arene supramolecular sensors for selective uranyl detection in environmental water samples.

Talanta·2025

County-Level Medical Debt and Its Associations With Cancer Stage and Survival in the United States.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Current Surgical Perspectives for Pleural Mesothelioma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

NCCN Guidelines® Insights: Survivorship, Version 3.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Metabolic Tumor Volume as a Predictor of Benefit From Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Technology-Enabled Patient and Physician Activation to Enhance Skin Cancer Screening After HCT: A Randomized Controlled Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Efficacy and safety of low-dose tirofiban plus dual antiplatelet therapy in acute cerebral infarction beyond the thrombolysis window: a non-randomized trial with preliminary findings.

Journal of thrombosis and thrombolysis·2026

HCC within LR-M on CEUS LI-RADS: preliminary analysis of washout timing & intensity.

Abdominal radiology (New York)·2026

[Retracted] Engulfment of platelets delays endothelial cell aging via girdin and its phosphorylation.

International journal of molecular medicine·2026

Belzutifan in Von Hippel-Lindau-associated Hemangioblastomas: A Systematic Review and Meta-analysis.

Journal of neurological surgery. Part B, Skull base·2026

Renal artery stenting for atherosclerotic renal artery stenosis: A review of contemporary data.

World journal of nephrology·2026

Redefining atherosclerotic cardiovascular disease patients with no standard modifiable risk factors "SMuRF-less": six rather than four risk factors. Analysis from the Jordan SMuRF-less Study.

Frontiers in cardiovascular medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us